Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 590 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Diagnostic Ultrasound System Clear all

Conditions: DMG, DIPG
Interventions: TAA-T Cell, BBB Disruption; Biological · Device
Lead sponsor: Children's National Research Institute; Other
Eligibility: 3 Years to 25 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Prostate Cancer
Interventions: Photodynamic Therapy (PDT), Verteporfin Injection; Device · Drug
Lead sponsor: SpectraCure AB; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Chest Wrinkles
Interventions: Ulthera System Treatment; Device
Lead sponsor: Ulthera, Inc; Industry
Eligibility: 35 Years to 70 Years · Female only
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 4
States / cities: Sacramento, California • San Diego, California • Chicago, Illinois + 1 more

Conditions: Chronic Kidney Disease, Hemodialysis Access, Arteriovenous Fistula, End Stage Renal Disease (ESRD)
Interventions: Velocity Percutaneous Arteriovenous Fistula; Device
Lead sponsor: Venova Medical; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 13
States / cities: Dothan, Alabama • Concord, California • Riverside, California + 9 more

Conditions: Feasibility Assessment of the VxWave Device for Vascular Access Imaging
Interventions: Robotic Tomographic ultrasound imaging of the arm vasculature.; Diagnostic Test
Lead sponsor: Vexev Pty Ltd; Industry
Eligibility: 21 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Healthy
Interventions: Ultrasound; Device
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 20 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Advanced Non CNS Tumors
Interventions: Talimogene Laherparepvec; Drug
Lead sponsor: Amgen; Industry
Eligibility: 2 Years to 21 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 9
States / cities: Wilmington, Delaware • Jacksonville, Florida • Chicago, Illinois + 6 more

Conditions: Peripheral Arterial Disease
Interventions: Balloon Angioplasty, Atherectomy System; Device
Lead sponsor: Mercator MedSystems, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Little Rock, Arkansas • Bossier City, Louisiana • Hattiesburg, Mississippi + 3 more

Conditions: Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma
Interventions: Microwave ablation; Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 5
States / cities: Duarte, California • Rochester, Minnesota • New York, New York + 2 more

Conditions: Pancreatic Mucinous-Cystic Neoplasm
Interventions: NanoPac®; Drug
Lead sponsor: NanOlogy, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 4
States / cities: Fort Wayne, Indiana • Columbus, Ohio • El Paso, Texas + 1 more

Conditions: Menorrhagia
Interventions: Intrauterine Ultrasound-Guided Radiofreq. Ablation System; Device
Lead sponsor: Gynesonics; Industry
Eligibility: 25 Years to 50 Years · Female only
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 22
States / cities: Phoenix, Arizona • Denver, Colorado • Newark, Delaware + 19 more

Conditions: Endstage Renal Disease
Interventions: Ultrasound scan; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Evergreen Park, Illinois

Conditions: Pulmonary Hypertension (PH) Due to Left Heart Disease
Interventions: Pulmonary Denervation; Device
Lead sponsor: SoniVie Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 3
States / cities: San Diego, California • San Francisco, California • Boston, Massachusetts

Conditions: Overactive Bladder (OAB)
Interventions: NT 201 200U and Vibe System, NT 201 300U and Vibe System, Placebo and sham; Combination Product
Lead sponsor: Vensica Therapeutics Ltd.; Industry
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Margate, Florida • Pompano Beach, Florida • Reno, Nevada

Conditions: Muscle Atrophy, Proximal, Muscle Atrophy, ACL Tear, Quadriceps Muscle Atrophy
Interventions: 892.1550 Ultrasonic pulsed doppler imaging system, Thigh circumference measurement; Device · Diagnostic Test
Lead sponsor: Robert Westermann; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Treatment-Resistant Depression
Interventions: Low-intensity focused ultrasound; Other
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Spinal Cord Injuries, Tendinopathy, Rotator Cuff Tears, Shoulder Pain
Interventions: Lipogems, Dexamethasone; Device · Drug
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Breast Tumor
Interventions: RFID Localization, Wire Localization, RFID and Wire Localization; Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Prostate Adenocarcinoma, Prostate Cancer
Interventions: Transvesical Single Port Robotic Partial Prostatectomy, High-intensity focused ultrasound (HIFU); Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older · Male only
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Atrial Fibrillation, Oral Anticoagulation, Stroke, Implant
Interventions: Vine Filter; Device
Lead sponsor: Javelin Medical; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 6
States / cities: Rockford, Illinois • Boston, Massachusetts • New York, New York + 2 more

Conditions: Carpal Tunnel Syndrome
Interventions: FDA approved ultrasound system with shear wave elastography capability; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Conditions: Atrial Fibrillation, Hypertension
Interventions: catheter ablation, renal sympathetic denervation; Procedure
Lead sponsor: Meshalkin Research Institute of Pathology of Circulation; Network
Eligibility: 18 Years to 75 Years
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Short Hills, New Jersey

Conditions: Lymphatic System
Interventions: Not listed
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 142 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Covid19, Cytokine Storm, Inflammation
Interventions: Splenic Ultrasound; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Burnsville, Minnesota • Saint Paul, Minnesota

Search by objective public record fields.

Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

Evaluation of the Ulthera System for the Treatment of the Decolletage

Pivotal Study of the Velocity™ pAVF System

Feasibility Study of Dialysis Clinic Semi-Autonomous Ultrasound Scanning Using the Vexev Ultrasound Imaging System for Arteriovenous Fistula Mapping Examinations. The CANSCAN Trial.

The ULTRA Study: Cross-Comparison of Ultrasound Systems

Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors

DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes

NEUWAVE Flexible Probe Study #2

Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms

Sonography Guided Transcervical Ablation of Uterine Fibroids

Data Collection for Next Generation Ultrasound Technology Development

TReatment of Pulmonary Hypertension Group II Study

RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

Ultrasound for Rectus Femoris Measurement

Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury

Radiofrequency Chip for Localization of Non-Palpable Breast Lesions

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

Assessment of Carpal Tunnel Syndrome by Shearwave Elastography

Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation

Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway

UNITE Study (UMN-SW) for COVID-19